Journal of Immunotherapy for Cancer

Correction: Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Pub Date : 2022-04-01 DOI: 10.1136/jitc-2021-003439corr1

P855 High-resolution maps of heterogeneous antigen expression in glioblastoma and implications for immunotherapy

Pub Date : 2020-04-01 DOI: 10.1136/LBA2019.10 M. Barish, L. Weng, Dina Awabdeh, Blake Brewster, M. D’Apuzzo, Yubo Zhai, Alfonso Brito, B. Chang, Annie Sarkissian, R. Starr, W. Chang, B. Aguilar, A. Naranjo, S. Blanchard, Russell C. Rockne, B. Badie, Vanessa Jonsson, Stephen J. Forman, Christine Brown

P860 Results from a combination of OX40 (PF-04518600) and 4–1BB (utomilumab) agonistic antibodies in melanoma and non-small cell lung cancer in a phase 1 dose expansion cohort

Pub Date : 2020-04-01 DOI: 10.1136/LBA2019.14 A. Chiappori, John A Thompson, F. Eskens, J. Spano, T. Doi, O. Hamid, A. Diab, N. Rizvi, S. Hu-Lieskovan, W. Ros, Jacob S. Thomas, A. Forgie, Wenjing Yang, K. Liao, Ray Li, Farhad Kazazi, J. Chou, A. E. Khoueiry